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We begin m this Issue a Seminar compnsmg a senes of
ongmal contnbunons as well as reviews on contrast echo-
cardiography, a field that IS now undergoing dynamic changes
through development of new echogemc contrast agents and
mnovanve methods that promise to greatly advance the range
of apphcations After extensive, Important, yet largely em-
pineal use m diagnostic studies, there are mdications that
contrast echocardiography will now be placed on a more
scientific basis through elucidation of fundamental mecha-
msms of ultrasound imaging in the presence of contrast
solutions with optimal physicochemical properties and spe-
cifically controlled gaseous rmcrobubbles The newest con-
trast agents already contain much smaller and more umform
rmcrobubbles than heretofore, and should be safer and more
suitable for vanous echo contrast studies requinng unhm-
dered passage throughout the rmcrocrrculations
Among the most exciting vistas presented III the Seminar
IS an assessment of regional cardiac muscle perfusion through
myocardial contrast two-dimensional echocardiography Al-
though very substantial research, development and vahda-
tion will certainly be required, It IS already apparent that
several echogemc contrast agents and methods of adrmn-
istration dunng myocardial echographic studies should be
practical for detecnng and outhmng the extent of significant
perfusion deficiencies Contrast-enhanced delineation of re-
gional perfusion defects, along With quanntauon of myo-
cardial contracnon abnormalities III the same region, rep-
resents a major advance With potentially far-reaching
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consequences to chmcal diagnostic practice Even more am-
bitIOUS developments have as their goal the contrast echo
assessment of the actual level and distnbunon of myocardial
perfusion in normal and ischemic states Computenzed anal-
ysis of the spatial distnbution and temporal course of con-
trast-induced myocardial echo mtensities dunng admmis-
tranon of nontoxic contrast solutions IS hkely to provide
standardized procedures for charactenzing normal as well
as pathologic states of myocardial perfusion It IS mcreas-
mgly evident that evaluation of epicardial coronary artery
anatomy and flow, and assessment of stenotic lesions, even
With the most sophisticated computenzed angiographic
methods, cannot be fully rehed on to charactenze regional
myocardial perfusion which bear a direct relation to regional
metabohsm, contraction and electncal function When added
to the echocardiographic study of cardiac anatomy and con-
tractile function, enhanced myocardial contrast echographic
methods should provide substantially greater mformation
for assessment of pathophysiology and for deCISIOns relative
to treatment of coronary artery disease
Historical Perspective
It has been recogmzed that intravascular mjection of cer-
tam substances results m altered echo reflecnons caused by
a change III acoustic Impedance of the medium, an effect
referred to as contrast echocardiography The first reported
observation of the phenomenon was made purely by ser-
endipity dunng an mvestiganon that necessitated obtammg
M-mode echocardiograms dunng mtracardiac injections of
mdocyarune green at the time of cardiac cathetenzation
Gramiak and Shah (I) reported this effect and utilized It to
explore and confirm M-mode echographic anatomy through
vanous transducer mampulauons Feigenbaum et al (2)
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subsequently reproduced these observations Thus, aortic
root, aortic valve and left ventncular outflow anatomy as
recorded by M-mode echocardiography were rdenufied and
confirmed
Effects of abnormal systolic antenor motion of the mitral
valve In hypertrophic cardiomyopathy were also docu-
mented with contrast echo Many mvestiganons used pe-
npheral venous mjections to identify and confirm mtracar-
diac shunts, and the method has also been applied to detect
valvular regurgitation (3-8) The advent of two-dimensional
echocardiography provided a natural extension of the M-
mode echo contrast technique (9-12) The cross-sectional
anatomy visualized from multiple transducer locations per-
nuts Improved spatIal onentation, and passage of contrast
medium across valves and through mtracardiac defects IS
more accurately delineated (13)
Mechanisms of the Contrast Effect
The underlymg mechanisms of echo contrast appear to
be related to introduction of gaseous rrucrobubbles in so-
lution It was apparent from the early m VItro studies by
Krernkau et al (14) that turbulence was not responsible for
this effect, but rather cavitation or microbubble formation
Thus, vigorous shakmg durmg preparation of mdocyanme
green mtroduced atmosphenc rmcrobubbles mto solution
Subsequently, It was noted that agitated saline or dextrose
In water provided similar contrast effects The density, SIze
and distnbution of rrncrobubbles In solution IS mfluenced
by numerous physical factors, mcludmg temperature, VIS-
COSIty and pressure of gas above liquid These factors are
the subject of ongomg mvestigatrons
Clinical Safety
The Issue of safety of contrast echocardiography IS quite
relevant because rmcrobubbles are being mtroduced mto the
circulation, especially on the left SIde General expenence
in most laboratones suggests the technique to be free of
significant SIde effects, even when used in mfants WIth nght
to left shunts A systematic survey was recently made by a
special task force of the Amencan SOCIety of Echocardi-
ography The results, as reported by Bommer et al (15),
indicate a relatively low level of risk, WIthout residual SIde
effects or significant cornphcatrons Nevertheless, appro-
pnate caution IS still advised m the use of this method
because a recent case report (16) descnbed a localized cere-
brovascular defect that occurred after contrast echocardi-
ography but was fully reversed within 24 hours It would
seem from studies reported m this Semmar that a major
reason for the more womsome SIde effects may be potential
blockage of regional rmcrocirculation due to entry of a suf-
ficient number of large rrncrobubbles WhICh also distort
physiologic measurements
Quantitation of Echo Contrast Agents
Despite extensive cluneal apphcation of hand-agitated
echo contrast agents, there has been a lack of systematic
studies of these agents, mcludmg assessment of the SIze of
rrucrobubbles The uunal quantitative approach consisted
of developmg gelatm encapsulated microbubbles of air, and
early expenmental studies were camed out WIth rrncrobub-
bles of 30 to 40 JL Current attempts to manufacture smaller
rmcrobubbles are under way As descnbed in this Semmar,
Femstem et al (17) and Smith et al (18) camed out studies
to assess newer agents Thus, Smith reports on a supenor
and better standardized agent (SHU 454) for nght heart
mjections (18), Femstem performed a systematic in VItro
mvestigatton to assess the SIze and range of microbubbles
in a vanety of echo contrast agents They also developed a
new methodology applymg sorncanon to cavitate and agitate
a solution WIth admixture of surface air Their observations
demonstrate that. 1) somcation produces smaller and more
uniform rrncrobubbles as compared WIth hand-agitated agents,
and 2) somcation of more VISCOUS echogemc agents such as
Renografin-sahne, 70% dextrose and 70% sorbitol produces
persistent and fairly uniform rmcrobubbles WIth a diameter
of less than 10 JL Prehrnmary mvestiganon m a microcir-
culatory cat mesentenc preparation suggests that such so-
luuons are capable of passmg through capillaries WIthout
significant Impedance, m contrast to blockage observed fol-
lowing introduction of larger bubbles (FIg 1)
Transpulmonary Contrast Echocardiography
Ten Cate and co-workers (19) explored the efficacy of
sonicated solutions to cross the pulmonary crrculation after
injection Into the nght heart chamber or pulmonary artery,
and studied their appearance m the left-SIded cardiac cham-
bers Their results demonstrate consistent production of left
heart echoes WIth nght heart injections Further extension
and apphcation of thrs prelimmary work IS expected to yield
practical cluneal apphcations The report of Levme et al
(20), which also appears In this Issue of lACC, shows that
rrncrobubbles m the pulmonary artery have similar intra-
cardiac velocities to those of red blood cells ThIS mfor-
matron needs to be expanded to the microcirculation where
It may be relevant m regard to transpulmonary contrast
echocardiographic apphcations
Myocardial Opacification and Study of
Perfusion Defects
Parallel mdependent mvestiganons in two laboratones,
namely one at Indiana University in Indianapolis and another
at Cedars-Sinai Medical Center In Los Angeles, have pro-
vided some mnovative observations on contrast two-dimen-
sional echocardiographic study of myocardial perfusion de-





Figure 1. Blockage of microcirculation resulting from large mi-
crobubbles. These sequential images (each frame = 1I400th sec-
ond) of microvessels in a cat mesenteric preparation* show a
blocked capillary with two large microbubbles, which followed
injection of a hand-agitated saline-Renografin echo contrast agent
(average size 16 ± 13 f.L). In the same preparation, smaller mi-
crobubbles after injections of sonicated 70% sorbitol (average 6
± 2 f.L) appeared to flow through the microvessels without no-
ticeable impedance.
*These studies on microcirculation were carried out in the re-
search laboratories of Dr. Richard Bing at Huntington Memorial
Hospital, Pasadena, California. We gratefully acknowledge per-
mission from Drs. Steven Feinstein and Richard Bing for use of
this illustration.
feets. In their initial reports on dog experiments, Armstrong
et al. (21) described injection of hydrogen peroxide into the
aortic root, while Tei et al. (22) used small amounts of
hand-agitated Renografin-saline mixtures injected directly
into the coronary artery tree. Both have reported excellent
anatomic delineation of myocardial segments in echographic
cross sections. Further validation of such delineation of
myocardial perfusion defects is reported by Sakamaki and
co-workers (23) in this issue of the Seminar. They used
injection of monastral blue dye before sacrificing the animal,
and compared the outlined perfusion deficit after a coronary
branch occlusion with contrast delineation.
An increasing number of experimental studies using a
variety of echo contrast agents are demonstrating that two-
dimensional echocardiography with intracoronary or aortic
root contrast injections may indeed satisfactorily establish
both the site and extent of a perfusion defect, particularly
in the presence of a major reduction in regional coronary
blood flow such as might be anticipated in patients with
evolving acute myocardial infarction. In such patients, it
would be extremely desirable to obtain information regard-
ing the initial myocardial perfusion defect and regional per-
fusion, and to follow the progress throughout individual
stages of treatment such as surgical or nonsurgical reper-
fusion. As this Seminar suggests, new echo contrast agents
may eventually permit myocardial defect study with pul-
monary artery, aortic root, coronary sinus or systemic in-
travenous administration. Several articles by DeMaria et al.
(18), Feinstein et al. (17) and Ten Cate et al. (19) address
the issue of contrast agents that can readily pass through
the microcirculation of the lung and also myocardium. Pro-
vided that safety, lack of toxicity and effective myocardial
opacification with echo contrast agents are corroborated,
two-dimensional echocardiography should allow compre-
hensive regional and global reconstruction study of perfu-
sion defects from multiple cross-sections of the heart. This
new and minimally invasive echo contrast method should
then take its place alongside current radionuclide techniques
and equally innovative developments in the field of digital
angiography.
Contrast Echocardiographic Assessment of
Myocardial Perfusion
One of the most challenging tasks, which is now receiv-
ing increasing attention, is the development of a comput-
erized myocardial contrast two-dimensional echographic
method capable of assessing the extent of myocardial per-
fusion deficiencies and ultimately quantitating regional
myocardial perfusion. The initial studies reported in this
Seminar indicate difficulties yet to be overcome, including
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opnrruzation of contrast agents for phYSIOlogIC myocardial
microcirculatory transit and accurate computenzed mea-
surement of contrast-Induced myocardial echo mtensities
Conversely, the potential envisioned IS a new, essentially
nOnInVaSIVe, econorrucal and convement method for even-
tual evaluation of regional myocardial perfusion and as-
sessment of perfusion gradients from endocardium to epi-
cardium or from profoundly ischerruc toward lateral border
segments of the heart
Some may wonder whether such a new contrast echo
method IS really needed In VIew of the advances made In
computenzed coronary angiography, which rmght In the
future allow satisfactory quantrtation of coronary anatomy
and flow as well as measurementof even complexcoronary
stenosis Yet, valuable as such coronary artery measure-
ments Will certainly be, they cannot provide defimuve data
on regional myocardial perfusion and ItS distnbution be-
cause they are based on Images of the epicardial vessel
which mainly provide anatomic mformation about stenosis
Interpretation of angiographic measurements reveals that
they are but a crude estimate and are often far from accurate,
even when reviewed by foremost experts There are other
hmitations Thus, extravascular mtramyocardial stress gra-
dients In vanous physiologic states can redistribute myo-
cardial blood flow away from endocardial and toward epi-
cardial layers In fact, nonurufornunes of regional myocardial
wallperfusionare quite common, and Influence significantly
regional cardiac funcuon and tissue vrabihty Another lim-
itation of SImply studying epicardial vessels of the heart IS
related to effects of mtramyocardial collateral vessels that
can alter the extent as well as the seventy of regional myo-
cardial underperfusion Thus, In spite of the many tech-
nologic hurdles yet to be overcome, methods that address
quantitative measurement of regional perfusion deserve to
be vigorously pursued
As an ObVIOUS firstextensionof these myocardial contrast
echocardiographic measurements of the SIze of severe per-
fUSIOn defects, one contnbunon to this Seminar addresses
assessment of myocardial deficiencies distal to coronary
stenoses of diffenng seventy Tel et al (24) applied com-
puter analysis of contrast-Induced myocardial echo mtensity
appearance-disappearance after mtracoronary contrast agent
mjections In closed chest dogs WIth mtracoronary stenotic
plugs The use of the then current agents, With relatively
large rrncrobubbles (hand-agitated salme-Renografin), con-
stituted a clear hrmtanon of this study because physiologic
rmcrocirculatory transit time was evidentlynot attained Yet
the Investigation may be valuable In that It suggests direc-
tions for future development, mcludmg the need of agents
WIth much smaller microbubbles It also highhghts other
Important factors, such as the agent-Induced hyperemia.
As part of essential validations dunng the current myo-
cardial contrastecho development,correlations have already
been performed against electromagnetic probe measure-
ments of coronary flow, and more appropnate validations
against radionuchde measurements of regional myocardial
perfusion are being pursued Quanutanon of myocardial
perfusion WIll require standardization of computer echo
methods and accurate assessment of regional tissue echo
intensities Ultrasound factors that contnbute to regional
vanability In echo intensity distnbution Include transducer
properties, such as focusing profile, ultrasound attenuation
and actual echo SIgnal processing In most current two-
dimensional echocardrographic equipment, Image process-
mg IS nonlinear, compresses the received echo amplitude
and IS pnmanly aimed at optimal delmeation of cardiac
structures and tissue to blood Interfaces
Other Developments
Several of these myocardial contrast echo factors are
currently under intensive study, particularly development
of appropnate modes of contrast adnumstration and stand-
ardized methods for contrast Image acquisition, processing
and computer analysis The resulting contrast echocardio-
graphic data are being expenmentally validated against
myocardial blood flow measurements Other excitmg new
developments of contrast echocardiography Include the po-
tential for estimations of cardiac output and quantitanon of
shunts and regurgitant lesions Many of these tOpICS WIll be
covered In subsequent Issues of this Seminar The editors
WIll bnng these Intofocus Ina concludingeditonal comment
m the final Issue of the Seminar
In summary, VIgOroUS efforts are underway to develop a
quantitative method for myocardial contrast echocardiog-
raphy The potentIals are considerable We enVISIOn in-
creasing emphasis on developing safe and effective contrast
agents, Improved methods of adrmrustratron and new com-
putenzed techniques of contrast echo analysis, WIth a VIew
to charactenzmg myocardial perfusion defects and mea-
surement of regional perfusion Appropnately designed and
validated myocardial contrast echo methodsare expected to
be applied as relatively mexpensive but valuable techniques
potennally SUItable for the practmoner's office, the stress
laboratory and for continuous and Improved surveillance In
the coronary care facility
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